Search This Blog

Thursday, November 14, 2019

Amarin shares halted pending news

Nasdaq has suspended trading in Amarin (NASDAQ:AMRN) pending the release of news. In this case, it is the outcome of an FDA advisory committee meeting today on a CV benefit claim for Vascepa (icosapent ethyl).
Posted by at

No comments:

Post a Comment

Note: Only a member of this blog may post a comment.

Subscribe to: Post Comments (Atom)